The clinical application value of cytokines in treating infectious diseases

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Ye, Qing ^a   Shao, Wen Xia ^b   Xu, Xiao Jun ^a   Yang, Ying Zhi ^c  

^a CHILDREN S HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^c ZHEJIANG UNIVERSITY CITY COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; AREA UNDER THE CURVE; ARTICLE; BACTERIAL MENINGITIS; BACTERIUM IDENTIFICATION; BRAIN CONTUSION; BRAIN INFECTION; BRONCHIOLITIS; BRONCHITIS; CHILD; CONTROLLED STUDY; ENCEPHALITIS; ENTERITIS; FEMALE; FLOW CYTOMETRY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; HYDROCEPHALUS; INFANT; JAUNDICE; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OMPHALITIS; PNEUMONIA; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; SKULL FRACTURE; SUBDURAL HEMATOMA; TONSILLITIS; UPPER RESPIRATORY TRACT INFECTION; GRAM-NEGATIVE BACTERIAL INFECTIONS; NEWBORN; PRESCHOOL CHILD;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; CYTOKINES; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROSPECTIVE STUDIES;

EID: 84902352282     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098745     Document Type: Article

References (30)

1. Watson RS, Carcillo JA (2005) Scope and epidemiology of pediatric sepsis. Pediatric Critical Care Medicine 6: S3-S5. (Pubitemid 40724243)
2. Wolfler A, Silvani P, Musicco M, Antonelli M, Salvo I (2008) Incidence of and mortality due to sepsis, severe sepsis and septic shock in Italian Pediatric Intensive Care Units: a prospective national survey. Intensive Care Medicine 34: 1690-1697.
3. Hartman ME, Linde-Zwirble WT, Angus DC, Watson RS (2013) Trends in the Epidemiology of Pediatric Severe Sepsis. Pediatric Critical Care Medicine: 1.
4. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Lidicker J, et al. (2003) The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 167: 695-701. (Pubitemid 36801744)
5. Ye Q, Xu X, Zheng Y, Chen X (2011) Etiology of septicemia in children with acute leukemia: 9-year experience from a children's hospital in China. J Pediatr Hematol Oncol 33: e186-191.
6. Xu X-J, Tang Y-M, Liao C, Song H, Yang S-L, et al. (2012) Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock. Intensive Care Medicine 39: 319-326.
7. Foerster BR, Thurnher MM, Malani PN, Petrou M, Carets-Zumelzu F, et al. (2007) Intracranial infections: Clinical and imaging characteristics. Acta Radiologica 48: 875-893. (Pubitemid 47551928)
8. Goldstein B, Giroir B, Randolph A (2005) International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics*. Pediatric Critical Care Medicine 6: 2-8.
9. Sharma R, Fu SM, Ju S-T (2011) IL-2: A two-faced master regulator of autoimmunity. Journal of Autoimmunity 36: 91-97.
10. de la Rosa M, Rutz S, Dorninger H, Scheffold A (2004) Interleukin-2 is essential for CD4+CD25+ regulatory T cell function. Eur J Immunol 34: 2480-2488. (Pubitemid 39302805)
11. Sharma R, Sharma PR, Kim YC, Leitinger N, Lee JK, et al. (2010) IL-2-Controlled Expression of Multiple T Cell Trafficking Genes and Th2 Cytokines in the Regulatory T Cell-Deficient Scurfy Mice: Implication to Multiorgan Inflammation and Control of Skin and Lung Inflammation. The Journal of Immunology 186: 1268-1278.
12. Hirano T (1992) Interleukin-6 and its relation to inflammation and disease. Clinical Immunology and Immunopathology 62: S60-S65.
13. Fonseca JE, Santos MJ, Canhão H, Choy E (2009) Interleukin-6 as a key player in systemic inflammation and joint destruction. Autoimmunity Reviews 8: 538-542.
14. Castell JV, Gomez-Lechon MJ, David M, Hirano T, Kishimoto T, et al. (1988) Recombinant human interleukin-6 (IL-6/BSF-2/HSF) regulates the synthesis of acute phase proteins in human hepatocytes. FEBS Lett 232: 347-350.
15. Veldhuis GJ, Willemse PH, Sleijfer DT, van der Graaf WT, Groen HJ, et al. (1995) Toxicity and efficacy of escalating dosages of recombinant human interleukin-6 after chemotherapy in patients with breast cancer or non-small-cell lung cancer. J Clin Oncol 13: 2585-2593.
16. Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, et al. (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: Evidence in Crohn disease and experimental colitis in vivo. Nat Med 6: 583-588. (Pubitemid 30305911)
17. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220.
18. Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O'Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815-3822.
19. de Waal Malefyt R, Yssel H, de Vries JE (1993) Direct effects of IL-10 on subsets of human CD4+ T cell clones and resting T cells. Specific inhibition of IL-2 production and proliferation. J Immunol 150: 4754-4765. (Pubitemid 23150343)
20. Jinquan T, Quan S, Jacobi HH, Madsen HO, Glue C, et al. (2000) CXC chemokine receptor 4 expression and stromal cell-derived factor-1alpha-induced chemotaxis in CD4+ T lymphocytes are regulated by interleukin-4 and interleukin-10. Immunology 99: 402-410. (Pubitemid 30137705)
21. Groux H, Bigler M, de Vries JE, Roncarolo MG (1996) Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 184: 19-29. (Pubitemid 26247211)
22. Sciuca S, Neamtu L, Magalu V (2013) Evaluation of levels of IL-2 in Mycoplasma pneumoniae infection in children with respiratory tract diseases. Allergy 68: 347-347.
23. Jenabian M-A, Seddiki N, Yatim A, Carriere M, Hulin A, et al. (2013) Regulatory T Cells Negatively Affect IL-2 Production of Effector T Cells through CD39/Adenosine Pathway in HIV Infection. PLoS Pathog 9: e1003319.
24. Salinas N, Olguin J, Castellanos C, Saavedra R (2013) T cell-suppression during acute Toxoplasma gondii infection does not involve APC and is a consequence of Treg-mediated IL-2 deprivation and death of proliferating T cells. Journal of Immunology 190.
25. Finney SJ, Leaver SK, Evans TW, Burke-Gaffney A (2011) Differences in lipopolysaccharide- and lipoteichoic acid-induced cytokine/chemokine expression. Intensive Care Medicine 38: 324-332.
26. DeClue AE, Johnson PJ, Day JL, Amorim JR, Honaker AR (2012) Pathogen associated molecular pattern motifs from Gram-positive and Gram-negative bacteria induce different inflammatory mediator profiles in equine blood. The Veterinary Journal 192: 455-460.
27. Markham JL, Knox KW, Wicken AJ, Hewett MJ (1975) Formation of extracellular lipoteichoic acid by oral streptococci and lactobacilli. Infect Immun 12: 378-386.
28. Beveridge TJ (1999) Structures of gram-negative cell walls and their derived membrane vesicles. J Bacteriol 181: 4725-4733.
29. Richens JL, Urbanowicz RA, Metcalf R, Corne J, O'Shea P, et al. (2010) Quantitative validation and comparison of multiplex cytokine kits. Journal of biomolecular screening 15: 562-568.
30. Leng SX, McElhaney JE, Walston JD, Xie D, Fedarko NS, et al. (2008) ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 63: 879-884.